XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Mar. 27, 2021
Mar. 28, 2020
OPERATING ACTIVITIES    
Net income $ 1,272,800,000 $ 480,700,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 41,500,000 42,300,000
Amortization of acquired intangibles 146,500,000 145,800,000
Stock-based compensation expense 35,600,000 33,800,000
Deferred income taxes (23,500,000) (44,200,000)
Intangible asset and equipment impairment charges 0 30,200,000
Debt extinguishment loss 21,600,000 0
Other adjustments and non-cash items 18,900,000 14,800,000
Changes in operating assets and liabilities, excluding the effect of acquisitions:    
Accounts receivable (171,400,000) (300,000)
Inventories (46,000,000.0) (33,300,000)
Prepaid income taxes (46,600,000) (27,700,000)
Prepaid expenses and other assets (36,700,000) (317,600,000)
Accounts payable 32,800,000 (47,900,000)
Accrued expenses and other liabilities (50,100,000) (50,800,000)
Deferred revenue 6,800,000 5,800,000
Net cash provided by operating activities 1,202,200,000 231,600,000
INVESTING ACTIVITIES    
Acquisition of businesses, net of cash acquired (440,000,000.0) (43,200,000)
Proceeds From Sale Of Business 0 142,700,000
Capital expenditures (51,700,000) (29,600,000)
Increase in equipment under customer usage agreements (27,800,000) (33,500,000)
Purchase of insurance contracts 1,600,000 2,400,000
Purchase of intellectual property (6,500,000) 0
Other activity (500,000) (1,400,000)
Net cash (used in) provided by investing activities (528,100,000) 32,600,000
FINANCING ACTIVITIES    
Repayment of long-term debt (37,500,000) (27,100,000)
Proceeds from Notes Payable 950,000,000.0 0
Repayments of Senior Debt (970,800,000) 0
Proceeds from revolving credit line 0 750,000,000.0
Repayment under revolving credit line (250,000,000.0) 0
Proceeds from accounts receivable securitization agreement 0 16,000,000.0
Repayments of Accounts Receivable Securitization 0 (250,000,000.0)
Payments to Noncontrolling Interests 0 (1,700,000)
Payment of deferred acquisition consideration 0 (24,300,000)
Payment of debt issuance costs (13,700,000) 0
Repurchase of common stock (221,400,000) (553,500,000)
Proceeds from issuance of common stock pursuant to employee stock plans 33,600,000 36,600,000
Payment of minimum tax withholdings on net share settlements of equity awards (46,700,000) (12,500,000)
Payments under finance lease obligations (900,000) (800,000)
Net cash used in financing activities (557,400,000) (67,300,000)
Effect of exchange rate changes on cash and cash equivalents (1,300,000) 1,100,000
Net increase in cash and cash equivalents 115,400,000 198,000,000.0
Cash and cash equivalents, beginning of period 701,000,000.0 601,800,000
Cash and cash equivalents, end of period $ 816,400,000 $ 799,800,000